Sagefield Capital’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,300
Closed -$335K 180
2022
Q2
$335K Buy
+2,300
New +$335K 0.15% 78